SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-044694
Filing Date
2019-08-08
Accepted
2019-08-08 07:01:58
Documents
3
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-16836_18k.htm 8-K 27166
2 EX-99.1 a19-16836_1ex99d1.htm EX-99.1 391935
3 GRAPHIC g168361mmi001.jpg GRAPHIC 4613
  Complete submission text file 0001104659-19-044694.txt   426828
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 191007412
SIC: 2834 Pharmaceutical Preparations